Prognostic value of vegf in patients submitted to percutaneous coronary intervention

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Ramos, Catarina ^a,b   Napoleão, Patrícia ^c   Selas, Mafalda ^b   Freixo, Cláudia ^b   Viegas Crespo, Ana Maria ^d   Mota Carmo, Miguel ^b,e   Rui, Cruz Ferreira ^b,e   Pinheiro, Teresa ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b HOSPITAL DE SANTA MARTA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d UNIVERSITY OF LISBON   (Portugal)

^e NOVA MEDICAL SCHOOL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PRESCRIPTION DRUG; VASCULOTROPIN; BIOLOGICAL MARKER; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DISEASE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; LIMIT OF DETECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; SYNTAX SCORE; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904654506     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/135357     Document Type: Article

References (36)

1. Carmeliet P., Jain R. K., Molecular mechanisms and clinical applications of angiogenesis. Nature 2011 473 7347 298 307 10.1038/nature10144 2-s2.0-79956328903
2. Simons M., An inside view: VEGF receptor trafficking and signaling. Physiology 2012 27 4 213 222 10.1152/physiol.00016.2012 2-s2.0-84864947743
3. Horowitz J. R., Rivard A., van der Zee R., Hariawala M., Sheriff D. D., Esakof D. D., Muqtada Chaudhry G., Symes J. F., Isner J. M., Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension: Evidence for a maintenance role in quiescent adult endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 11 2793 2800 10.1161/01.ATV.17.11.2793 2-s2.0-0031471950 (Pubitemid 28016023)
4. Zachary I., Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. American Journal of Physiology-Cell Physiology 2001 280 6 C1375 C1386 2-s2.0-0034979275 (Pubitemid 32553192)
5. Chang Z., Hong L., Wang H., Lai H., Li L., Yin Q., Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models. Journal of Cardiothoracic Surgery 2013 8 1, article 33 10.1186/1749-8090-8-33 2-s2.0-84874398700
6. Vestweber D., VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 223 232 10.1161/ATVBAHA.107.158014 2-s2.0-38549128935 (Pubitemid 351161193)
7. dela Paz N. G., Walshe T. E., Leach L. L., Saint-Geniez M., D'Amore P. A., Role of shear-stress-induced VEGF expression in endothelial cell survival. Journal of Cell Science 2012 125 4 831 843 10.1242/jcs.084301 2-s2.0-84861207235
8. Walshe T. E., Dole V. S., Maharaj A. S. R., Patten I. S., Wagner D. D., D'Amore P. A., Inhibition of VEGF or TGF- β signaling activates endothelium and increases leukocyte rolling. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1185 1192 10.1161/ATVBAHA.109.186742 2-s2.0-68149168790
9. Lee S., Chen T. T., Barber C. L., Jordan M. C., Murdock J., Desai S., Ferrara N., Nagy A., Roos K. P., Iruela-Arispe M. L., Autocrine VEGF Signaling Is Required for Vascular Homeostasis. Cell 2007 130 4 691 703 10.1016/j.cell.2007.06.054 2-s2.0-34547941252 (Pubitemid 47268059)
10. Bates D. O., Vascular endothelial growth factors and vascular permeability. Cardiovascular Research 2010 87 2 262 271 10.1093/cvr/cvq105 2-s2.0-77954333963
11. Maloney J. P., Silliman C. C., Ambruso D. R., Wang J., Tuder R. M., Voelkel N. F., In vitro release of vascular endothelial growth factor during platelet aggregation. American Journal of Physiology. Heart and Circulatory Physiology 1998 275 3 H1054 H1061 2-s2.0-0031688684
12. Lee S. H., Wolf P. L., Escudero R., Deutsch R., Jamieson S. W., Thistlethwaite P. A., Early expression of angiogenesis factors in acute myocardial ischemia and infarction. The New England Journal of Medicine 2000 342 9 626 633 10.1056/NEJM200003023420904 2-s2.0-0034594876 (Pubitemid 30118415)
13. Cotton J. M., Mathur A., Hong Y., Brown A. S., Martin J. F., Erusalimsky J. D., Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery. European Heart Journal 2002 23 12 953 959 10.1053/euhj.2001.3034 2-s2.0-0036623841 (Pubitemid 35203874)
14. Heeschen C., Dimmeler S., Hamm C. W., Boersma E., Zeiher A. M., Simoons M. L., Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation 2003 107 4 524 530 10.1161/01.CIR.0000048183.37648.1A 2-s2.0-0037418035 (Pubitemid 36176799)
15. Korybalska K., Pyda M., Kawka E., Grajek S., Breborowicz A., Witowski J., Interpretation of elevated serum VEGF concentrations in patients with myocardial infarction. Cytokine 2011 54 1 74 78 10.1016/j.cyto.2011.01.003 2-s2.0-79952072879
16. Kim S.-Y., Lee S.-H., Park S., Kang S., Chung N., Shim W., Cho S., Manabe I., Jang Y., Vascular endothelial growth factor, soluble Fms-like tyrosine kinase 1, and the severity of coronary artery disease. Angiology 2011 62 2 176 183 10.1177/0003319710370963 2-s2.0-78651410622
17. Kranz A., Rau C., Kochs M., Waltenberger J., Elevation of vascular endothelial growth factor A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. Journal of Molecular and Cellular Cardiology 2000 32 1 65 72 10.1006/jmcc.1999.1062 2-s2.0-0033971166 (Pubitemid 30064305)
18. Banerjee S., Brilakis E., Zhang S., Roesle M., Lindsey J., Philips B., Blewett C. G., Terada L. S., Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006 189 1 70 75 10.1016/j.atherosclerosis.2006.04.026 2-s2.0-33748976490 (Pubitemid 44441298)
19. Kochiadakis G. E., Marketou M. E., Panutsopulos D., Arfanakis D. A., Skalidis E. I., Igoumenidis N. E., Hamilos M. I., Sourvinos G., Chlouverakis G., Spandidos D., Vardas P. E., Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents. European Heart Journal 2008 29 6 733 740 10.1093/eurheartj/ehn060 2-s2.0-41149139339 (Pubitemid 351431032)
20. + endothelial precursor cells. Circulation Research 2001 88 2 167 174 10.1161/01.RES.88.2.167 2-s2.0-0035793330 (Pubitemid 32147304)
21. Silvestre J. S., Smadja D. M., Lévy B. I., Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiological Reviews 2013 93 4 1743 1802
22. Alber H. F., Frick M., Dulak J., Dörler J., Zwick R.-., Dichtl W., Pachinger O., Weidinger F., Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease. Heart 2005 91 3 365 366 10.1136/hrt.2003.021311 2-s2.0-14244266866 (Pubitemid 40299222)
23. Eaton C. B., Gramling R., Parker D. R., Roberts M. B., Lu B., Ridker P. M., Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England. Atherosclerosis 2008 200 1 221 227 10.1016/j.atherosclerosis.2007.12.027 2-s2.0-49749132363
24. Kim B. H., Ko Y., Her A., Kim J., Hwang K., Shin D., Kim B., Choi D., Ha J., Hong M., Jang Y., Serial plasma levels of angiogenic factors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circulation Journal 2012 42 7 464 470 10.4070/kcj.2012.42.7.464 2-s2.0-84865328018
25. Uhlemann M., Adams V., Lenk K., Linke A., Erbs S., Adam J., Thiele H., Hilberg T., Gutberlet M., Grunze M., Schuler G. C., Möbius-Winkler S., Impact of different exercise training modalities on the coronary collateral circulation and plaque composition in patients with significant coronary artery disease (EXCITE trial): study protocol for a randomized controlled trial. Trials 2012 13, article 167 10.1186/1745-6215-13-167 2-s2.0-84866174764
26. Sandri M., Adams V., Gielen S., Linke A., Lenk K., Kränkel N., Lenz D., Erbs S., Scheinert D., Mohr F. W., Schuler G., Hambrecht R., Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 2005 111 25 3391 3399 10.1161/CIRCULATIONAHA.104.527135 2-s2.0-21544457751 (Pubitemid 40923392)
27. Mischie A. N., Nazzaro M. S., Fiorilli R., De Felice F., Musto C., Confessore P., Parma A., Boschetti C., Violini R., Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study. Catheterization and Cardiovascular Interventions 2013 82 3 E184 E191 10.1002/ccd.24844 2-s2.0-84883239725
28. Pendyala L. K., Yin X., Li J., Chen J. P., Chronos N., Hou D., The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC: Cardiovascular Interventions 2009 2 12 1169 1177 10.1016/j.jcin.2009.10.004 2-s2.0-72149107100
29. Lampugnani M. G., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T. O., Dejana E., Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β -catenin, and the phosphatase DEP-1/CD148. Journal of Cell Biology 2003 161 4 793 804 10.1083/jcb.200209019 2-s2.0-0038699077 (Pubitemid 36648762)
30. Gampel A., Moss L., Jones M. C., Brunton V., Norman J. C., Mellor H., VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. Blood 2006 108 8 2624 2631 10.1182/blood-2005-12-007484 2-s2.0-33748756029
31. Wallez Y., Cand F., Cruzalegui F., Wernstedt C., Souchelnytskyi S., Vilgrain I., Huber P., Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 2007 26 7 1067 1077 10.1038/sj.onc. 1209855 2-s2.0-33847050140
32. Mattila E., Auvinen K., Salmi M., Ivaska J., The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling. Journal of Cell Science 2008 121 21 3570 3580 10.1242/jcs.031898 2-s2.0-59149103545
33. Lacal P. M., Morea V., Ruffini F., Orecchia A., Dorio A. S., Failla C. M., Soro S., Tentori L., Zambruno G., Graziani G., Tramontano A., D'Atri S., Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide. European Journal of Cancer 2008 44 13 1914 1921 10.1016/j.ejca.2008.06.032 2-s2.0-49549085264
34. Ahmad S., Hewett P. W., Al-Ani B., Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. Cell 2011 3 15
35. Di Marco G. S., Reuter S., Hillebrand U., Amler S., König M., Larger E., Oberleithner H., Brand E., Pavenstädt H., Brand M., The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. Journal of the American Society of Nephrology 2009 20 10 2235 2245 10.1681/ASN.2009010061 2-s2.0-70349895636
36. Jelkmann W., Pitfalls in the measurement of circulating vascular endothelial growth factor. Clinical Chemistry 2001 47 4 617 623 2-s2.0-0035060498 (Pubitemid 32275802)